Lexeo's LX2020 Data and a Wider Q3 Loss: What the Quarter Means for LXEO
Lexeo paired heart-rhythm data and an FDA signal on a surrogate endpoint with a larger third-quarter loss. Shares gapped up in pre-market trading on Nov. 16, then gave back part of the gain.


